About Ensysce biosciences

About company

We’re a biotech company committed to stemming the prescription drug abuse epidemic. Our proprietary prodrug technologies: abuse resistant TAAP™ and overdose resistant MPAR™ are designed to improve the care of patients with chronic pain while reducing the human and economic costs associated with prescription drug abuse. In addition to working with all known prescription opioid drugs, our abuse-resistant drug technologies TAAP™ and MPAR™ have broad potential across a variety of other drugs with the possibility of abuse. For example, we currently have multiple TAAP™ products in the pipeline including one for ADHD.